Willow Biosciences Inc.
WLLW.TO
TSX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -8.84% | 7.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -8.84% | 7.67% | |||
| Cost of Revenue | 144.04% | -269.00% | |||
| Gross Profit | -89.87% | 2,043.81% | |||
| SG&A Expenses | -27.05% | -15.08% | |||
| Depreciation & Amortization | -96.26% | 13.90% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -22.80% | -9.63% | |||
| Operating Income | 63.15% | 38.29% | |||
| Income Before Tax | 75.30% | -12.84% | |||
| Income Tax Expenses | -- | -309.01% | |||
| Earnings from Continuing Operations | 65.57% | 29.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 65.57% | 29.78% | |||
| EBIT | 63.15% | 38.29% | |||
| EBITDA | 17.02% | 68.33% | |||
| EPS Basic | 66.67% | 30.77% | |||
| Normalized Basic EPS | 74.36% | -11.43% | |||
| EPS Diluted | 66.67% | 30.77% | |||
| Normalized Diluted EPS | 74.36% | -11.43% | |||
| Average Basic Shares Outstanding | 1.77% | 0.85% | |||
| Average Diluted Shares Outstanding | 1.77% | 0.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||